定制出生体重百分位与胎盘相关胎儿生长受限
该研究为前瞻性队列的二次分析,纳入857例低危初产妇,比较定制与人群出生体重百分位定义的SGA对胎盘异常病理的诊断准确性。结果显示定制百分位对任何胎盘病理、母体血管灌注不良、慢性绒毛炎和胎儿血管灌注不良的检出率更高,假阳性率相似,提示其可能更优。
要点
- 定制百分位定义的SGA与任何胎盘病理、MVM、慢性绒毛炎和FVM风险增加相关。
- 定制百分位对任何胎盘病理、MVM和慢性绒毛炎的检出率高于人群百分位,假阳性率相似。
- 定制百分位组SGA妊娠更易并发早产和5分钟Apgar评分低,人群百分位组则无此关联。
核心结论
- 定制出生体重百分位在检测由潜在胎盘疾病所致的胎儿生长受限方面可能优于人群出生体重百分位。
研究设计与样本
- 研究为前瞻性队列研究的二次分析,纳入857例低危初产妇,所有胎盘均由两名围产期病理学家进行详细组织病理学检查。
- 主要暴露为SGA,定义为出生体重低于同胎龄第10百分位,分别采用定制(SGAcust)或人群(SGApop)出生体重参考标准。
- 关注结局为与FGR相关的三种胎盘异常病理之一:母体血管灌注不良(MVM)、慢性绒毛炎和胎儿血管灌注不良(FVM)。
- 采用改良Poisson回归分析估计调整相对风险(aRR)及95%CI,调整因素包括吸烟、体重指数和阿司匹林治疗。
诊断标准与关键数值
- SGAcust与SGApop的SGA比例分别为12.6%(108/857)和11.4%(98/857)。
- SGAcust与任何胎盘病理风险增加相关(aRR 3.04,95%CI 2.29-4.04),SGApop亦相关(aRR 1.60,95%CI 1.10-2.31)。
- SGAcust与MVM病理风险增加相关(aRR 12.33,95%CI 6.60-23.03),SGApop亦相关(aRR 5.29,95%CI 2.87-9.76)。
- SGAcust与慢性绒毛炎风险增加相关(aRR 1.85,95%CI 1.07-3.18),SGApop无此关联。
- SGAcust与FVM病理风险增加相关(aRR 2.48,95%CI 1.25-4.93),SGApop无此关联。
临床应用与阅片要点
- SGAcust组妊娠较相应非SGA组更可能并发早产和5分钟Apgar评分低,SGApop组则无此关联。
- SGAcust较SGApop检出率更高主要源于白人和东亚亚组中异常病理检出率更高,以及南亚亚组中异常病理假阳性率更低。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: The value of using customized birth-weight centiles to improve the diagnostic accuracy for fetal growth restriction (FGR), in comparison with using population-based charts, remains a matter of debate. One potential explanation for the conflicting data is that most studies used measures of perinatal mortality and morbidity as proxies for placenta-mediated FGR, many of which are not specific and may be confounded by other factors such as prematurity. The aim of this study was to compare the diagnostic accuracy of small-for-gestational age (SGA) at birth, defined according to customized vs population-based charts, for associated abnormal placental pathology.
METHODS: This was a secondary analysis of data from a prospective cohort study on risk factors for placenta-mediated complications and abnormal placental pathology in low-risk nulliparous women. All placentae were sent for detailed histopathological examination by two perinatal pathologists. The primary exposure was SGA, defined as birth weight < 10th centile for gestational age using either a customized (SGAcust ) or a population-based (SGApop ) birth-weight reference. The outcomes of interest were one of three types of abnormal placental pathology associated with FGR: maternal vascular malperfusion (MVM), chronic villitis and fetal vascular malperfusion (FVM). Adjusted relative risks (aRR) with 95% CIs were estimated using modified Poisson regression analysis, with adjustment for smoking, body mass index and aspirin treatment.
RESULTS: A total of 857 nulliparous women met the study criteria. The proportions of infants identified as SGA based on the customized and population-based charts were 12.6% (108/857) and 11.4% (98/857), respectively. A diagnosis of SGA using either customized or population-based charts was associated with an increased risk of any placental pathology (aRR, 3.04 (95% CI, 2.29-4.04) and 1.60 (95% CI, 1.10-2.31), respectively) and MVM pathology (aRR, 12.33 (95% CI, 6.60-23.03) and 5.29 (95% CI, 2.87-9.76), respectively). SGAcust , but not SGApop , was also associated with an increased risk for chronic villitis (aRR, 1.85 (95% CI, 1.07-3.18)) and FVM pathology (aRR, 2.48 (95% CI, 1.25-4.93)). SGAcust had a higher detection rate for any placental pathology (30.3% vs 17.1%; P < 0.001), MVM pathology (63.2% vs 39.5%; P = 0.003) and chronic villitis (20.8% vs 8.3%; P = 0.007) than did SGApop , for a similar false-positive rate. This was mainly the result of a higher detection rate for abnormal pathology in the white and East-Asian subgroups and a lower false-positive rate for abnormal pathology in the South-Asian subgroup by SGAcust than by SGApop . In addition, pregnancies in the SGAcust group, but not those in the SGApop group, were more likely to be complicated by preterm birth and a low 5-min Apgar score than were the corresponding non-SGA group.
CONCLUSION: These findings suggest that customized birth-weight centiles may be superior to population-based birth-weight centiles in detecting FGR that is due to underlying placental disease. © 2020 International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Melamed N, Hiersch L, Aviram A, et al. Customized birth-weight centiles and placenta-related fetal growth restriction. Ultrasound Obstet Gynecol. 2021. PMID: 33073889. doi:10.1002/uog.23516
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。